Many studies have shown that the expression level of Hsp90-beta is closely related to the prognosis of cancer patients, indicating that over-expression of Hsp90-beta promotes the progression of malignant tumors and may be a prognostic indicator of malignant tumors [11, 14, 27–29]. Here, HSP90AB1 is linked to cancer.